Back to Archived Journals » Core Evidence » Volume 13
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 13, 2018
Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy
Lattanzi S, Brigo F, Cagnetti C, Verrotti A, Zaccara G, Silvestrini M
Core Evidence 2018, 13:21-31
Published Date: 8 March 2018
Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis
Eshtiaghi P, Gooderham MJ
Core Evidence 2018, 13:13-20
Published Date: 23 February 2018
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety, efficacy, and place in therapy
Brousell SC, Fantony JJ, Van Noord MG, Harrison MR, Inman BA
Core Evidence 2018, 13:1-12
Published Date: 24 January 2018